Endothelial Myocyte Matrix in Cardiac Remodeling
Endothelial Myocyte Matrix in Cardiac Remodeling
批准号:
8267028
负责人:
Suresh C. Tyagi
金额:
$36.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-05 至 2014-05-31
关键词:
AbbreviationsAcetylcholineAcidsAntigensAntioxidantsAortaApoptosisArteriesArteriovenous fistulaBasement membraneBradykininCD31 AntigensCardiacCellsChronicClinicalCoinCollagenCongestive Heart FailureCouplingCpG Island Methylator PhenotypeCystathionineCytoskeletonDiastoleDiastolic blood pressureDiastolic heart failureDilated CardiomyopathyDisulfidesEchocardiographyElastinEndothelial CellsEndotheliumEventExtracellular MatrixFibrosisFistulaFunctional disorderFundingGasesGelatinase AGelatinase BGenerationsGoalsHeartHeart failureHistologyHydrogen SulfideHydroxyeicosatetraenoic AcidsHypertrophyIn SituLaboratoriesLeftLeft ventricular structureLyaseMatrix MetalloproteinasesMeasuresMediatingMitochondriaMusMuscleMuscle CellsMyocardialNADHNADPH OxidaseNG-Nitroarginine Methyl EsterNicotinamide adenine dinucleotideNitric OxideNitric Oxide SynthaseNitroprussideNuclearOperative Surgical ProceduresOxidation-ReductionOxidative StressPAR-1 ReceptorPECAM1 genePoly(ADP-ribose) PolymerasesPreparationPrincipal InvestigatorProcessProstaglandinsProtein Kinase CProteomeRadiolabeledReactive Nitrogen SpeciesReactive Oxygen SpeciesRelaxationRoleSecondary toSodiumSourceStressSulfhydryl CompoundsSystemSystoleTechniquesTestingTimeTissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of Metalloproteinase-3Tissue Inhibitor of MetalloproteinasesVentricularWestern Blottingarginine methyl esterdrinking waterhuman NOS3 proteinin vivoinnovationnovelpreventprogramsradiotracerrelaxing factorresearch studyresponsesham surgerytissue inhibitor of metalloproteinase 4
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Program Director/Principal Investigator (Last, First, Middle): Tyagi, Suresh C.,
The overall goal of this project is to understand the mechanism of endocardial endothelial-myocyte (E-M)
dysfunction in chronic heart failure. Studies from the previous funding period suggested that endocardial
endothelial dysfunction is associated with increased oxidized-matrix accumulation (fibrosis), activation of latent
resident myocardial matrix metalloproteinases (MMPs) and inactivation of cardiac tissue inhibitor of
metalloproteinase (TIMP-4) secondary to oxidative and proteolytic stresses. Administration of TIMP-4
ameliorated both the formation of reactive oxygen species (ROS, oxidative stress) and MMP activation
(proteolytic stress). In addition, we discovered the induction of proteinase activated receptor-1 (PAR-1).
However, the role of PAR-1 in fibrosis and E-M uncoupling remains poorly defined. H2S gas is the most potent
antioxidant in mitigating oxidative stress and recent studies have implicated a cardioprotective role of H2S. The
central hypothesis of this competitive renewal proposal is that during chronic heart failure the oxidative and
proteolytic stresses induce PAR-1, leading to generate mitochondrial (mt) ROS and reactive nitrogen species
(RNS) and mitochondrial nitric oxide synthase (mtNOS), respectively, thus activating the latent resident cardiac
MMPs. These events disrupt the MMP/TIMP axis, causing fibrosis between endothelium and myocyte.
Treatment with H2S alleviates fibrosis and mitigates E-M uncoupling. Therefore, the specific aims of this
proposal are: #1: To determine whether chronic left ventricle (LV) volume overload causes mitochondrial
oxidative stress (ROS and RNS) by inducing NADPH oxidase (p47 subunit), mtNOS and PAR-1, and H2S
alleviates mitochondrial oxidative stress. #2: To determine whether chronic LV volume overload causes
cardiac fibrosis by increasing collagen/elastin ratio, MMP-2, -9, -13, TIMP-1, -3, decreasing TIMP-4, and
inducing PAR-1, and H2S mitigates cardiac fibrosis. #3: To determine whether chronic LV volume overload
causes E-M dysfunction and LVH by inducing PAR-1 and H2S decreases E-M uncoupling. Chronic heart failure
will be created by LV volume overload by aorta-venacava fistula (AVF) in wild type (WT), PAR-1-/+, iNOS-/-,
MMP-9-/-, TIMP-3-/-, and TIMP-4++/++ mice, treated with or without NaHS, a H2S donor.
PHS 398/2590 (Rev. 11/07) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Remote Hind Limb Ischemia Mechanism of Cardioprotection
-
批准号:10247852
-
项目类别:
-
资助金额:$6.49万
-
财政年份:2020
-
负责人:Suresh C. Tyagi
-
依托单位:
Reversing Skeletal Muscle Myopathy by Hydrogen Sulfide
-
批准号:10557832
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2018
-
负责人:Suresh C. Tyagi
-
依托单位:
Remote Hind Limb Ischemia Mechanism of Cardioprotection
-
批准号:10215605
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2018
-
负责人:Suresh C. Tyagi
-
依托单位:
Remote Hind Limb Ischemia Mechanism of Cardioprotection
-
批准号:10438112
-
项目类别:
-
资助金额:$10.45万
-
财政年份:2018
-
负责人:Suresh C. Tyagi
-
依托单位:
Reversing Skeletal Muscle Myopathy by Hydrogen Sulfide
-
批准号:10357570
-
项目类别:
-
资助金额:$33.54万
-
财政年份:2018
-
负责人:Suresh C. Tyagi
-
依托单位:
Reversing Skeletal Muscle Myopathy by Hydrogen Sulfide
-
批准号:10089145
-
项目类别:
-
资助金额:$32.86万
-
财政年份:2018
-
负责人:Suresh C. Tyagi
-
依托单位:
Mitophagic and anti-angiogenic mechanism of heart failure
-
批准号:8600989
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2011
-
负责人:Suresh C. Tyagi
-
依托单位:
Mitophagic and anti-angiogenic mechanism of heart failure
-
批准号:8258238
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2011
-
负责人:Suresh C. Tyagi
-
依托单位:
Mitophagic and anti-angiogenic mechanism of heart failure
-
批准号:8131312
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2011
-
负责人:Suresh C. Tyagi
-
依托单位:
Mitophagic and anti-angiogenic mechanism of heart failure
-
批准号:8403722
-
项目类别:
-
资助金额:$35.7万
-
财政年份:2011
-
负责人:Suresh C. Tyagi
-
依托单位:
Implications of Endothelial-Myocyte Uncoupling in Cardiac Arrhythmia
-
批准号:7408062
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Mechanisms of Cerebral Vascular Remodeling
-
批准号:7845565
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Mechanisms of Cerebral Vascular Remodeling
-
批准号:7315147
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Mechanisms of Cerebral Vascular Remodeling
-
批准号:8076171
-
项目类别:
-
资助金额:$31.73万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Mechanisms of Cerebral Vascular Remodeling
-
批准号:7414460
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Implications of Endothelial-Myocyte Uncoupling in Cardiac Arrhythmia
-
批准号:7797672
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Implications of Endothelial-Myocyte Uncoupling in Cardiac Arrhythmia
-
批准号:7242879
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Implications of Endothelial-Myocyte Uncoupling in Cardiac Arrhythmia
-
批准号:7597230
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Mechanisms of Cerebral Vascular Remodeling
-
批准号:7624309
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Inhibitor ameliorates oxidative and proteolytic strees
-
批准号:7340811
-
项目类别:
-
资助金额:$9.23万
-
财政年份:2003
-
负责人:Suresh C. Tyagi
-
依托单位:
海外基金